
Digital therapeutics for migraine and headache
Our solutions
The problem
Migraine, affecting 14% worldwide, is the leading cause of disability for young women globally
and ranks second across all genders. Its widespread yet underdiagnosed presence, with only half seeking treatment, underscores a crucial unmet medical need and a significant societal burden.

News
- Company newsMay 30, 2025
Press Release: Positive Clinical Trial Results for Cerebri for Migraine Prevention
Oslo, Norway – May 30, 2025 – Nordic Brain Tech, a leader in neurotechnology and digital therapeutics, today announced positive results from a randomized controlled trial evaluating Cerebri, its novel app- and sensor-based therapy for the preventive treatment of migraine.
- Brain TwinMay 23, 2025
Brain Twin Integrated in Electronic Health Record
Brain Twin is now available for primary care providers in Norway
- Company newsMay 21, 2025
Nordic Brain Tech Featured in Expert Panel at LSX Nordic Congress
For the first time, the LSX Nordic Congress took place in Norway, gathering innovators, investors, and thought leaders in life sciences and digital health.
Migraine is one of the most disabling diseases worldwide
The right tools can empower patients to understand their condition and regain control. Brain Twin is such an app. The app is user-friendly and includes a dark mode option for users with light sensitivity.
Explore Brain Twin